Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial.

Sheehan P, Jones P, Giurini JM, Caselli A, Veves A.

Plast Reconstr Surg. 2006 Jun;117(7 Suppl):239S-244S.

PMID:
16799391
2.
3.

Determinants and estimation of healing times in diabetic foot ulcers.

Zimny S, Schatz H, Pfohl M.

J Diabetes Complications. 2002 Sep-Oct;16(5):327-32.

PMID:
12200075
4.

A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks.

Snyder RJ, Cardinal M, Dauphinée DM, Stavosky J.

Ostomy Wound Manage. 2010 Mar 1;56(3):44-50.

5.

Topical silver for infected wounds.

Beam JW.

J Athl Train. 2009 Sep-Oct;44(5):531-3. doi: 10.4085/1062-6050-44.5.531.

6.

The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers.

Zimny S, Schatz H, Pfohl M.

Exp Clin Endocrinol Diabetes. 2004 Apr;112(4):191-4.

PMID:
15127323
7.

Differentiating diabetic foot ulcers that are unlikely to heal by 12 weeks following achieving 50% percent area reduction at 4 weeks.

Warriner RA, Snyder RJ, Cardinal MH.

Int Wound J. 2011 Dec;8(6):632-7. doi: 10.1111/j.1742-481X.2011.00860.x. Epub 2011 Sep 23.

PMID:
21951763
8.

Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers.

Li Z, Guo S, Yao F, Zhang Y, Li T.

J Diabetes Complications. 2013 Jul-Aug;27(4):380-2. doi: 10.1016/j.jdiacomp.2012.12.007. Epub 2013 Jan 26.

PMID:
23357650
9.

The use of PriMatrix, a fetal bovine acellular dermal matrix, in healing chronic diabetic foot ulcers: a prospective multicenter study.

Kavros SJ, Dutra T, Gonzalez-Cruz R, Liden B, Marcus B, McGuire J, Nazario-Guirau L.

Adv Skin Wound Care. 2014 Aug;27(8):356-62. doi: 10.1097/01.ASW.0000451891.87020.69.

PMID:
25033310
10.

Healing times and prediction of wound healing in neuropathic diabetic foot ulcers: a prospective study.

Zimny S, Pfohl M.

Exp Clin Endocrinol Diabetes. 2005 Feb;113(2):90-3.

PMID:
15772900
11.

Effect of oral nutritional supplementation on wound healing in diabetic foot ulcers: a prospective randomized controlled trial.

Armstrong DG, Hanft JR, Driver VR, Smith AP, Lazaro-Martinez JL, Reyzelman AM, Furst GJ, Vayser DJ, Cervantes HL, Snyder RJ, Moore MF, May PE, Nelson JL, Baggs GE, Voss AC; Diabetic Foot Nutrition Study Group.

Diabet Med. 2014 Sep;31(9):1069-77. doi: 10.1111/dme.12509. Epub 2014 Jun 19.

12.

Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.

Uccioli L, Giurato L, Ruotolo V, Ciavarella A, Grimaldi MS, Piaggesi A, Teobaldi I, Ricci L, Scionti L, Vermigli C, Seguro R, Mancini L, Ghirlanda G.

Int J Low Extrem Wounds. 2011 Jun;10(2):80-5. doi: 10.1177/1534734611409371.

PMID:
21693443
13.

A prospective, non comparative, multicenter study to investigate the effect of cadexomer iodine on bioburden load and other wound characteristics in diabetic foot ulcers.

Schwartz JA, Lantis JC 2nd, Gendics C, Fuller AM, Payne W, Ochs D.

Int Wound J. 2013 Apr;10(2):193-9. doi: 10.1111/j.1742-481X.2012.01109.x. Epub 2012 Nov 9.

PMID:
23136838
14.

The Role of a Silver Releasing Lipido-colloid Contact Layer in Venous Leg Ulcers Presenting Inflammatory Signs Suggesting Heavy Bacterial Colonization: Results of a Randomized Controlled Study.

Lazareth I, Meaume S, Sigal-Grinberg ML, Combemale P, Guyadec TL, Zagnoli A, Perrot JL, Sauvadet A, Bohbot S.

Wounds. 2008 Jun;20(6):158-66.

PMID:
25942521
15.

Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.

Hanft JR, Pollak RA, Barbul A, van Gils C, Kwon PS, Gray SM, Lynch CJ, Semba CP, Breen TJ.

J Wound Care. 2008 Jan;17(1):30-2, 34-7.

PMID:
18210954
16.

Early healing rates and wound area measurements are reliable predictors of later complete wound closure.

Cardinal M, Eisenbud DE, Phillips T, Harding K.

Wound Repair Regen. 2008 Jan-Feb;16(1):19-22. doi: 10.1111/j.1524-475X.2007.00328.x.

PMID:
18211575
17.

Use of an autologous leucocyte and platelet-rich fibrin patch on hard-to-heal DFUs: a pilot study.

Löndahl M, Tarnow L, Karlsmark T, Lundquist R, Nielsen AM, Michelsen M, Nilsson A, Zakrzewski M, Jörgensen B.

J Wound Care. 2015 Apr;24(4):172-4, 176-8. doi: 10.12968/jowc.2015.24.4.172.

PMID:
25853474
19.

Clinical and economic assessment of diabetic foot ulcer debridement with collagenase: results of a randomized controlled study.

Tallis A, Motley TA, Wunderlich RP, Dickerson JE Jr, Waycaster C, Slade HB; Collagenase Diabetic Foot Ulcer Study Group.

Clin Ther. 2013 Nov;35(11):1805-20. doi: 10.1016/j.clinthera.2013.09.013. Epub 2013 Oct 18.

20.

Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.

Tantawi TI, Gohar YM, Kotb MM, Beshara FM, El-Naggar MM.

J Wound Care. 2007 Oct;16(9):379-83.

PMID:
17987750

Supplemental Content

Support Center